Blog Archive
-
▼
2010
(70)
-
▼
June
(15)
- Sanofi-aventis and Metabolex : Exclusive Worldwide...
- MannKind : Study Showing AFREZZA(TM) Provides Comp...
- Diamyd Medical and Ortho-McNeil-Janssen Pharmaceut...
- Metabolex and Ortho-McNeil-Janssen Pharmaceuticals...
- Lexicon Pharmaceuticals : Data Describing LX4211 P...
- Avid Radiopharmaceuticals : Clinical Trial Advance...
- Wright Medical Group : Commercial Launch of the VA...
- Home Diagnostics and Nipro Diabetes Systems : Plan...
- Cyntellect And Boston University To Collaborate In...
- Zydus Cadila : novel orally administered GLP-1 ago...
- Omni Bio Pharmaceutical : FDA IND Clearance for Al...
- LifeScan Canada collaborates with country's first ...
- Forest Laboratories and TransTech Pharma : License...
- OrbusNeich : Effectiveness of OrbusNeich's Genous™...
- GENFIT : Two major pre-diabetes clinical trials wi...
-
▼
June
(15)
Monday, June 21, 2010
Wright Medical Group : Commercial Launch of the VALOR(R) Hindfoot Fusion Nail System
Jun 03, 2010 - Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced the full commercial launch of the VALOR(R) Hindfoot Fusion Nail - the most comprehensive and advanced surgical product for fusion of the ankle joint. The system was designed in conjunction with world-renowned foot and ankle surgeons to facilitate ankle fusion in the treatment of skeletal deformity, late-stage arthritis, or complications resulting from diabetes (neuro-osteoarthropathy). Since its initial pre-market availability announced in November of 2009, the system has been limited to use in a few centers in the U.S. gathering early clinical results... Wright Medical Group's Press Release -